The content on this site is intended for healthcare professionals only
Predicting survival in NSCLC patients with poor performance status in resource-c...
Dr Akhil Kapoor - Tata Memorial Hospital, Mumbai, India
5 Aug 2021
Oncogenesis: Lung cancer
Dr Edgardo Santos - Florida Precision Oncology, GenesisCare, Florida, USA
28 Jul 2021
Immunotherapy in lung cancer
Dr Luis Raez - Memorial Healthcare System, Hollywood, Florida, USA
28 Jul 2021
OncoAlert and ecancer weekly round up for July 19 - July 25, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
26 Jul 2021
Unmet medical needs and emerging data on EGFR exon 20 insertion mutation NSCLC a...
Prof Caicun Zhou - Shanghai Pulmonary Hospital, Shanghai, China
16 Jul 2021
Lineage plasticity in lung cancer- biological and therapeutic implications
Dr Triparna Sen - Memorial Sloan Kettering Cancer Center, New York, USA
16 Jul 2021
CodeBreaK 100: Patient-reported outcomes evaluating sotorasib in KRAS p.G12C mNS...
Dr Alex Spira - Virginia Cancer Specialists Research Institute, Fairfax, USA
6 Jul 2021
ASCO 2021: Lung roundup
Dr Luis Raez - Memorial Healthcare System, FL, USA
5 Jul 2021
Latest updates in exon 20 insertions focusing on targeted therapies, novel appro...
Dr Mathew Krebs, Dr Santiago Viteri, Dr Shirish Gadgeel and Prof Byoung Chul Cho
22 Jun 2021
Advances in lung cancer and current situation in Romania
Dr Serban Negru - University of Medicine and Pharmacy Victor Babes Timisoara, On...
21 Jun 2021
ALCSI: Raising lung cancer screening awareness in the US
Priyanka Senthil - American Lung Cancer Screening Initiative
17 Jun 2021
Patritumab deruxtecan (HER3-DXd) in EGFR inhibitor-resistant, EGFR-mutated NSCLC
Dr Christina Baik - University of Washington School of Medicine, Seattle, USA
11 Jun 2021